Citadel Advisors’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,736
Closed -$800 14668
2024
Q2
$800 Buy
+14,736
New +$1.21K ﹤0.01% 13911
2023
Q4
Sell
-26,917
Closed -$380 14730
2023
Q3
$380 Buy
+26,917
New +$713 ﹤0.01% 14071
2022
Q4
Sell
-65,234
Closed -$5K 15127
2022
Q3
$5K Sell
65,234
-3
-0% ﹤0.01% 12372
2022
Q2
$7K Sell
65,237
-201
-0.3% -$29 ﹤0.01% 12648
2022
Q1
$14K Hold
65,438
﹤0.01% 13329
2021
Q4
$30K Buy
65,438
+101
+0.2% +$50 ﹤0.01% 13479
2021
Q3
$29K Buy
65,337
+698
+1% +$341 ﹤0.01% 13579
2021
Q2
$32K Hold
64,639
﹤0.01% 13466
2021
Q1
$25K Buy
+64,639
New +$26.2K ﹤0.01% 13055

Other funds holding ICUCW

Citadel Advisors's ICUCW Position: Q3 2024 in Review

Citadel Advisors sold out of SeaStar Medical Holding Corp Warrant (ICUCW) in Q3 2024, closing a stake of 14,736 shares — an estimated $800 sold.

Citadel Advisors first reported a position in ICUCW in Q1 2021 and held it in 9 quarters. The position peaked at $32K in Q2 2021. 14 funds tracked by Wall St. Rank hold ICUCW as of Q3 2024.

  • Citadel Advisors reported no remaining SeaStar Medical Holding Corp Warrant position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 14,736 SeaStar Medical Holding Corp Warrant shares in Q3 2024, an estimated $800.
  • Citadel Advisors first reported a position in SeaStar Medical Holding Corp Warrant in Q1 2021 and held it in 9 quarters.
  • Citadel Advisors's SeaStar Medical Holding Corp Warrant position peaked at $32K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.